To date, L1CAM research in the cancer area has focused heavily on local responses in the tumor microenvironment (TME); the relationship between the L1CAM and systemic immune-inflammation landscape beyond the TME remains to be fully determined, especially in the patients with brain metastases from lung cancer. This evidence concerns the gene L1CAM and cancer.